Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 91 AL 105

Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials

McManus KR, Lapid MI, Forester BP, Mueller M, Hermida AP, Nykamp L, Harper DG, Seiner SJ, Sanghani S, Patrick R, Gentry MT, Kung S, Leal JC, Johnson EK, Petrides G.

J ECT. 2022 Sep 1;38(3):165-170. doi: 10.1097/YCT.0000000000000832. Epub 2022 Mar 1.

How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer's disease treatment?

Séguy L, Groo AC, Malzert-Fréon A.

Drug Discov Today. 2022 Jun;27(6):1575-1589. doi: 10.1016/j.drudis.2022.02.022. Epub 2022 Feb 25.

Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers

Golde TE.

Neurotherapeutics. 2022 Jan;19(1):209-227. doi: 10.1007/s13311-022-01201-2. Epub 2022 Feb 28.

Mechanisms of Acupuncture in Improving Alzheimer's Disease Caused by Mitochondrial Damage

Jiang YH, He JK, Li R, Chen ZH, Jia BH.

Chin J Integr Med. 2022 Mar;28(3):272-280. doi: 10.1007/s11655-022-3511-6. Epub 2022 Mar 1.

"Aducanumab" making a comeback in Alzheimer's disease: An old wine in a new bottle

Behl T, Kaur I, Sehgal A, Singh S, Sharma N, Makeen HA, Albratty M, Alhazmi HA, Felemban SG, Alsubayiel AM, Bhatia S, Bungau S.

Biomed Pharmacother. 2022 Apr;148:112746. doi: 10.1016/j.biopha.2022.112746. Epub 2022 Feb 26.

Challenges and Approaches of Drugs Such as Memantine, Donepezil, Rivastigmine, and Aducanumab in the Treatment, Control and Management of Alzheimer's Disease

Saeedi M, Mehranfar F.

Recent Pat Biotechnol. 2022;16(2):102-121. doi: 10.2174/1872208316666220302115901.

Medication reconciliation role and value in Alzheimer's disease treatment

Shen X, Zhang Q, Shao W, Shi J, Liu B.

Arq Neuropsiquiatr. 2022 Mar;80(3):233-239. doi: 10.1590/0004-282X-ANP-2021-0147.

Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy

Xi Y, Chen Y, Jin Y, Han G, Song M, Song T, Shi Y, Tao L, Huang Z, Zhou J, Ding Y, Zhang H.

J Control Release. 2022 May;345:38-61. doi: 10.1016/j.jconrel.2022.02.034. Epub 2022 Mar 4.

Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology

Kok FK, van Leerdam SL, de Lange ECM.

J Alzheimers Dis. 2022;87(1):51-81. doi: 10.3233/JAD-210607.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA)

Shim Y, Han HJ, Park KW, Kim BC, Park KH, Park MY, Kim HJ, Moon SY, Choi SH, Park KW, Yang DW, Yoon SJ, Kim SY, Youn YC, Choi H, Yoon KE, Cho HJ, Han SH.

J Alzheimers Dis. 2022;87(1):391-403. doi: 10.3233/JAD-215277.

Role of HSV-1 in Alzheimer's disease pathogenesis: A challenge for novel preventive/therapeutic strategies

Protto V, Marcocci ME, Miteva MT, Piacentini R, Li Puma DD, Grassi C, Palamara AT, De Chiara G.

Curr Opin Pharmacol. 2022 Apr;63:102200. doi: 10.1016/j.coph.2022.102200. Epub 2022 Mar 8.

Fatty acids as biomodulators of Piezo1 mediated glial mechanosensitivity in Alzheimer's disease

Ivkovic S, Major T, Mitic M, Loncarevic-Vasiljkovic N, Jovic M, Adzic M.

Life Sci. 2022 May 15;297:120470. doi: 10.1016/j.lfs.2022.120470. Epub 2022 Mar 10.

Reimagining cholinergic therapy for Alzheimer's disease

Giacobini E, Cuello AC, Fisher A.

Brain. 2022 Jul 29;145(7):2250-2275. doi: 10.1093/brain/awac096.

[Causal treatment of Alzheimer's disease: amyloid antibodies]

Pawlowski M, Warnecke T.

Inn Med (Heidelb). 2022 Sep;63(9):1000-1008. doi: 10.1007/s00108-022-01291-2. Epub 2022 Mar 15.

Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM

Byun J, Lee DY, Jeong CW, Kim Y, Rhee HY, Moon KW, Heo J, Hong Y, Kim WJ, Nam SJ, Choi HS, Park JI, Chun IK, Bak SH, Lee K, Byeon GH, Kim KL, Kim JA, Park YJ, Kim JH, Lee EJ, Lee SA, Kwon SO, Park SW, Kasani PH, Kim JK, Kim Y, Kim S, Jang JW.

Sci Rep. 2022 Mar 15;12(1):4451. doi: 10.1038/s41598-022-08595-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias